M. S. Ali, “Efficacy and Safety Profile of Lenalidomide vs Lenalidomide + R-CHOP in patients with Diffuse Large B Cell Lymphoma: A Systematic Review: Lenalidomide vs Lenalidomide + R-CHOP”, PJHS-Lahore, vol. 4, no. 08, pp. 71–77, Aug. 2023.